Por favor, use este identificador para citar o enlazar este ítem:
http://hdl.handle.net/10609/92216
Registro completo de metadatos
Campo DC | Valor | Lengua/Idioma |
---|---|---|
dc.contributor.author | Morales Bartolomé, Eva | - |
dc.contributor.author | Cots, Francesc | - |
dc.contributor.author | Comas, Merce | - |
dc.contributor.author | Belvis, Francesc | - |
dc.contributor.author | Riu, Marta | - |
dc.contributor.author | Salvadó, Margarita | - |
dc.contributor.author | Grau Cerrato, Santiago | - |
dc.contributor.author | Horcajada, Juan P. | - |
dc.contributor.author | Milagro Montero, Maria | - |
dc.contributor.author | Castells Oliveres, Xavier | - |
dc.contributor.author | Sala, María Luisa | - |
dc.contributor.other | Universitat Oberta de Catalunya (UOC) | - |
dc.date.accessioned | 2019-03-14T14:15:35Z | - |
dc.date.available | 2019-03-14T14:15:35Z | - |
dc.date.issued | 2012-05-23 | - |
dc.identifier.citation | Morales, E., Cots Reguant, F., Sala, M.L., Comas, M., Belvis, F., Riu, M., Salvado, M., Grau, S., Horcajada, J.P. & Milagro Montero, M.(2012). Hospital costs of nosocomial multi-drug resistant pseudomonas aeruginosa acquisition. BMC Health Services Research, 12(1). doi: 10.1186/1472-6963-12-122 | - |
dc.identifier.issn | 1472-6963MIAR | - |
dc.identifier.uri | http://hdl.handle.net/10609/92216 | - |
dc.description.abstract | We aimed to assess the hospital economic costs of nosocomial multi-drug resistant Pseudomonas aeruginosa acquisition. A retrospective study of all hospital admissions between January 1, 2005, and December 31, 2006 was carried out in a 420-bed, urban, tertiary-care teaching hospital in Barcelona (Spain). All patients with a first positive clinical culture for P. aeruginosa more than 48 h after admission were included. Patient and hospitalization characteristics were collected from hospital and microbiology laboratory computerized records. According to antibiotic susceptibility, isolates were classified as non-resistant, resistant and multi-drug resistant. Cost estimation was based on a full-costing cost accounting system and on the criteria of clinical Activity-Based Costing methods. Multivariate analyses were performed using generalized linear models of log-transformed costs. | en |
dc.language.iso | eng | - |
dc.publisher | BMC Health Services Research | - |
dc.relation.ispartof | BMC Health Services Research, 2012, 12(1) | - |
dc.relation.uri | https://bmchealthservres.biomedcentral.com/track/pdf/10.1186/1472-6963-12-122 | - |
dc.rights | CC BY | - |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | - |
dc.subject | antimicrobial resistance | en |
dc.subject | economic analysis | en |
dc.subject | hospital cost | en |
dc.subject | multi-drug resistance | en |
dc.subject | pseudomonas aeruginosa | en |
dc.subject | resistencia antimicrobiana | es |
dc.subject | análisis económico | es |
dc.subject | coste del hospital | es |
dc.subject | resistencia a múltiples fármacos | es |
dc.subject | pseudomonas aeruginosa | es |
dc.subject | resistència antimicrobiana | ca |
dc.subject | anàlisi econòmica | ca |
dc.subject | cost de l'hospital | ca |
dc.subject | resistència a múltiples fàrmacs | ca |
dc.subject | pseudomonas aeruginosa | ca |
dc.subject.lcsh | Drugs | en |
dc.title | Hospital costs of nosocomial multi-drug resistant pseudomonas aeruginosa acquisition | - |
dc.type | info:eu-repo/semantics/article | - |
dc.subject.lemac | Medicaments | ca |
dc.subject.lcshes | Medicamentos | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
dc.identifier.doi | 10.1186/1472-6963-12-122 | - |
dc.gir.id | AR/0000004245 | - |
dc.type.version | info:eu-repo/semantics/publishedVersion | - |
Aparece en las colecciones: | Articles Articles cientÍfics |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
costs.pdf | 275,33 kB | Adobe PDF | Visualizar/Abrir |
Comparte:
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons